JD Supra9h
Clinicaltrials.gov: Recent Action May Signal Increased Attention from FDA on Trial Data Reporting Compliance
The US Food and Drug Administration (FDA) recently issued a notice of noncompliance to the FADOI Foundation, citing the ...
US FDA drops web pages on improving clinical trial diversity
The U.S. Food and Drug Administration has pulled draft guidance from its website requiring companies to test medicines and ...
medtechdive1d
FDA webpages on clinical trial diversity removed after Trump orders
The website changes raise concerns about “the interference of politics with the study and the practice” of science and ...
The Dangers Hidden In CMS’ Drug Pricing Regulation
The IRA’s price controls discourage post-marketing research. The potential benefits from expanding access to the drug to ...
STAT5d
FDA purges material on clinical trial diversity from its site, showing stakes of Trump DEI ban
Following the Trump administration's DEI ban, the FDA's move to scrub webpages has ensnared many pages focused on ensuring ...
Pharm Exec17h
Challenges to Navigating the Pharmaceutical Regulatory Landscape
In the United States, the biomedical industry encounters numerous regulatory challenges in conducting nonclinical and ...
The FDA pulls key DEI initiative for cancer studies from its website
A Food and Drug Administration project to promote diversity in clinical studies of cancer treatments was removed from the ...
Hosted on MSN11d
The biggest challenges clinical trials will face in 2025
“As pharmaceutical companies shift their focus toward fewer, high-value therapeutic areas in light of the IRA’s drug price ...
U.S. News & World Report4d
US FDA Drops Web Pages on Improving Clinical Trial Diversity
"Poor representation in clinical trials reduces our understanding ... It was still accessible on the U.S. government's regulation.gov website. The FDA declined to comment, citing a pause on ...